Charles River Laboratories International (CRL) Return on Invested Capital (2010 - 2023)

Charles River Laboratories International's Return on Invested Capital history runs 14 years deep, the most recent figure standing at 1.55% for Q3 2023.

• In Q3 2023, Return on Invested Capital rose 102.0% year-over-year to 1.55%; the TTM figure through Jul 2023 stood at 1.55% (up 102.0% YoY), while the FY2021 annual figure was 0.18%, up 10.0% from the prior year.
• Return on Invested Capital for Q3 2023 stood at 1.55%, up from 0.91% in the prior quarter.
• The five-year high for Return on Invested Capital was 1.55% in Q3 2023, with the low at 0.02% in Q2 2020.
• The 5-year median for Return on Invested Capital is 0.04% (2021), against an average of 0.28%.
• The sharpest annual moves came in 2020 and 2023: Return on Invested Capital changed 0 bps in 2020, then surged 102 bps in 2023.
• Charles River Laboratories International's Return on Invested Capital stood at 0.02% in 2019, then grew by 9 bps to 0.02% in 2020, then jumped by 481 bps to 0.14% in 2021, then jumped by 331 bps to 0.61% in 2022, then jumped by 156 bps to 1.55% in 2023.
• Business Quant data shows CRL's Return on Invested Capital at 1.55% in Q3 2023, 0.91% in Q2 2023, and 0.61% in Q4 2022.